Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab

Lignende værker

• Efficacy of dupilumab as an alternative to corticosteroids in the treatment of exacerbations of allergic bronchopulmonary aspergillosis
  af: Masamitsu Hamakawa, et al.
  Udgivet: (2024-04-01)
• The Role of Dupilumab in Severe Asthma
  af: Fabio Luigi Massimo Ricciardolo, et al.
  Udgivet: (2021-08-01)
• Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
  af: Tjeerd van derVeer, et al.
  Udgivet: (2021-12-01)
• Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13
  af: Corrado Pelaia, et al.
  Udgivet: (2022-06-01)
• Assessment of the rapid effect of dupilumab in two cases of severe asthma comorbid with recurrent eosinophilic chronic rhinosinusitis after endoscopic sinus surgery
  af: Yoshiro Kai, et al.
  Udgivet: (2021-08-01)